More troubles for LevFin as Elan postponed
Elan, the Irish biotechnology group, had pulled the sale of Elan Drug Technologies, its delivery unit, because buyers could not secure the debt they needed, bankers said this week. Bain Capital, Candover and TPG were all interested in EDT, which was expected to fetch about Eu1bn.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts